Literature DB >> 30708041

Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicine.

Vladislav Strmiska1, Petr Michalek1, Tomas Eckschlager2, Marie Stiborova3, Vojtech Adam1, Sona Krizkova1, Zbynek Heger4.   

Abstract

So far multiple differences in prostate cancer-specific amino acids metabolism have been discovered. Moreover, attempts to utilize these alterations for prostate cancer diagnosis and treatment have been made. The prostate cancer metabolism and biosynthesis of amino acids are particularly focused on anaplerosis more than on energy production. Other crucial requirements on amino acids pool come from the serine, one‑carbon cycle, glycine synthesis pathway and folate metabolism forming major sources of interproducts for synthesis of nucleobases necessary for rapidly proliferating cells. Considering the lack of some amino acids biosynthetic pathways and/or their extraordinary importance for prostate cancer cells, there is a widespread potential for targeted therapeutic applications with no effect on non-malignant cells. This review summarizes the up-to-date knowledge of the importance of amino acids for prostate cancer pathogenesis with a special emphasis on potential applications of metabolic variabilities in the new oncologic paradigm of precision medicine.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mitochondria; Personalized medicine; Prostate; Sarcosine; Serine; Warburg effect

Mesh:

Substances:

Year:  2019        PMID: 30708041     DOI: 10.1016/j.bbcan.2019.01.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  8 in total

1.  SNAT2 is responsible for hyperosmotic induced sarcosine and glycine uptake in human prostate PC-3 cells.

Authors:  Carsten Uhd Nielsen; Nanna Friberg Krog; Ilham Sjekirica; Sidsel Strandgaard Nielsen; Maria L Pedersen
Journal:  Pflugers Arch       Date:  2022-09-29       Impact factor: 4.458

2.  New Insights into the Multivariate Analysis of SER Spectra Collected on Blood Samples for Prostate Cancer Detection: Towards a Better Understanding of the Role Played by Different Biomolecules on Cancer Screening: A Preliminary Study.

Authors:  Vlad Cristian Munteanu; Raluca Andrada Munteanu; Diana Gulei; Radu Mărginean; Vlad Horia Schițcu; Anca Onaciu; Valentin Toma; Gabriela Fabiola Știufiuc; Ioan Coman; Rareș Ionuț Știufiuc
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

3.  HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation.

Authors:  Zhenting He; Yingying Gao; Ting Li; Chaowen Yu; Liping Ou; Chunli Luo
Journal:  Int J Oncol       Date:  2022-02-22       Impact factor: 5.650

Review 4.  The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer.

Authors:  Eleazer P Resurreccion; Ka-Wing Fong
Journal:  Metabolites       Date:  2022-05-27

5.  Plectin is a regulator of prostate cancer growth and metastasis.

Authors:  Mark Buckup; Meghan A Rice; En-Chi Hsu; Fernando Garcia-Marques; Shiqin Liu; Merve Aslan; Abel Bermudez; Jiaoti Huang; Sharon J Pitteri; Tanya Stoyanova
Journal:  Oncogene       Date:  2020-11-20       Impact factor: 9.867

6.  Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancer.

Authors:  Seiji Hoshi; Satoru Meguro; Hitomi Imai; Yuta Matsuoka; Yuki Yoshida; Akihumi Onagi; Ryo Tanji; Ruriko Honda-Takinami; Kanako Matsuoka; Tomoyuki Koguchi; Junya Hata; Yuichi Sato; Hidenori Akaihata; Masao Kataoka; Soichiro Ogawa; Yoshiyuki Kojima
Journal:  Cancer Sci       Date:  2021-03-11       Impact factor: 6.716

Review 7.  Metabolic reprogramming in prostate cancer.

Authors:  Fahim Ahmad; Murali Krishna Cherukuri; Peter L Choyke
Journal:  Br J Cancer       Date:  2021-07-14       Impact factor: 9.075

Review 8.  Alcohol and Prostate Cancer: Time to Draw Conclusions.

Authors:  Amanda J Macke; Armen Petrosyan
Journal:  Biomolecules       Date:  2022-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.